Europe Market Report for Hyaluronic Acid Viscosupplementation 2017 – MedCore

Europe Market Report for Hyaluronic Acid Viscosupplementation 2017 – MedCore

0

Osteoarthritis is a condition marked by the degeneration of bone joints and cartilage. Patients who suffer from osteoarthritis experience acute joint pain, tenderness, stiffness, creaking, locking of the joints and inflammation. These symptoms are caused by the degeneration of joint cartilage, subchondral bone and synovial fluid, specifically the polysaccharide hyaluronate. Cartilage and synovial fluid are important for absorbing stress and cushioning joints during normal activity. Progressive deterioration of cartilage and an overactive immune response may also lead to muscle atrophy and chronic disability. Hyaluronic acid (HA) is an anionic, nonsulfated glycosaminoglycan that is naturally present in the human body. It is mainly concentrated in fluids in the joints. Its function is to provide cushioning for joints. Individuals who suffer from osteoarthritis are deficient in these fluids. One of the treatment options for these patients is HA viscosupplementation injections.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 6/1/2017
  • Pages: 494
  • Type: MedCore

General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
Single-Injection Products
Single-injection products are the fastest growing products on the market. As per their name, they require only a single-injection per course of treatment. They are less popular in regions like Italy and Germany, where the costs of the three- and five-injection treatments are relatively low.
Two-Injection Products
Two-injection products are the newest products on this market. As per their name, they require only two-injection per course of treatment.
Three-Injection Cycle Products
Three-injection cycle products are administered once per week for three weeks. These products are generally more popular with patients than their five-injection cycle counterparts, mainly because they require fewer visits to a doctor’s office for the administration of the product. However, a number of products can be used in either three- or five-injection treatments.
Five-Injection Cycle Products
Five-injection cycle products are administered once per week for five weeks. The therapeutic effects generally become apparent to the patients near the end of the therapy cycle, and will last for up to six months. Five-injection cycle is particularly popular in countries where there is a monetary incentive per patient visits for doctors. This has the effect of making the five-injection cycle products more popular with doctors, as the profit per course of treatment is higher.



The "Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Fidia
Medtronic
TRB Chemedica
Meda Pharma
Sanofi Genzyme
Depuy Synthes
Bioventus
Laboratoire Genevrier
Recordati
Stryker
RTI Biologics
Croma-Pharma
Zimmer Biomet
Others include: Anika Therapeutics, Bioiberica, Documedica, Ferring, Geistlich, Integra Biologics, Kuros, LCA Pharma, Orotech, Plasmaconcept AG, Stella PharmaceuticalsAlphatec Spine, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link